Cobe marketing Research Industries bypass catheters worldwide.
This article was originally published in The Gray Sheet
Executive SummaryCOBE TO MARKET RESEARCH INDUSTRIES' BYPASS CATHETERS WORLDWIDE via a three-year distribution agreement signed the week of Nov. 20. Under the deal, Cobe will include Research Industries' specialty bypass circuitry and cardioplegia catheters with its oxygenator and heart/lung bypass tubing circuit line packs for use in open-heart surgery procedures. Research Industries will also continue to market the devices on its own.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.